Emerging Trends and Drug Treatments in Oral Oncology
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cancer Biology and Oncology".
Deadline for manuscript submissions: closed (15 December 2022) | Viewed by 239
Special Issue Editors
Interests: antioxidants; oxidative stress; selective killing; apoptosis; natural products; oral cancer; UVC; radiation
Interests: tumor biology; signal transduction; chemoresistance; programmed cell death; natural products
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Oral cancer is increasing annually for both genders. Mounting reports demonstrate that more sensitive and novel technologies are developed to detect oral cancer. This improvement provides an early diagnosis of oral cancer and may reduce its death rate. Moreover, several synthetic drugs and natural products were rapidly discovered against different cancers, enhancing their applications for oral cancer treatments. Moreover, combined treatments or natural product extracts(with defined molecular compound）have the potential for multiple targeting against oral cancer treatments. Drugs showing different types of cell deaths are also welcome, providing numerous choices for oral cancer treatment. Therefore, the novel detection and drug discovery against oral cancer warrant a detailed investigation.
This Special Issue aims to host research and review papers on developing novel methodology and technology for oral cancer detection and identifying novel drug treatment or combined treatment for antiproliferation purposes of oral cancer cells. This holds a great promise for improved oral cancer detection and remedies in the future.
Prof. Dr. Hsueh-Wei Chang
Prof. Dr. Chien-Chih Chiu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- oral cancer detection
- oral cancer diagnosis
- oral cancer prognosis
- antiproliferation
- apoptosis
- non-apoptosis
- synthetic drugs for antioral cancer
- natural products for antioral cancer
- combined treatments for antioral cancer
- drug repurposing for antioral cancer
